Sign up to The Irish Times Archive (1859 - 2008)My Account »

BIOTECH GROUP Elan has had talks with investors about the possible sale of its Athlone drug delivery business over the last month.

It is considering splitting Athlone-based Elan Drug Technology (EDT), which develops methods for administering medicines to patients, from the biotechnology business, which is focused on developing new products.